Voyager Therapeutics, Inc. (VYGR) NASDAQ

4.26

+0(+0.00%)

Updated at November 11 04:00PM

Currency In USD

Valuation

Market Cap326.97M
Enterprise Value299.33M
P/E Ratio-1.98
PEG Ratio0.12
Price/Sales Ratio7.56
Price/Book Ratio1.14
Enterprise/Revenue7.35
Enterprise/EBITDA-2.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-4.05
Operating Margin-3.5

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.49

Income Statement

Revenue80M
Revenue/Share0.53
Gross Profit80M
EBITDA-78.56M
Net Income-65M
Diluted EPS-1.13

Balance Sheet

Total Cash208.93M
Total Cash/Share3.55
Total Debt38.37M
Total Debt/Equity0.17
Current Ratio6.19
Book Value Per Share3.74

Price History

52-Week Change-37.63
52-Week High7.44
52-Week Low2.65
Moving Average 50 Days4.52
Moving Average 200 Days3.84

Statistics

Average Volume696,152
Shares Outstanding55.6M
% Held by Institutions56.55

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A